cannaQIX® 50, the company’s proprietary buccally formulated cannabidiol (CBD) lozenge product for chronic pain is due to be imported by Health … Read More
The post CPH signs deal to import and distribute its first human cannabinoid product into Australia appeared first on Dagga Magazine.